Real-time enrollment status for this advanced melanoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:32 AM UTC
| NCT Number | NCT06264180 |
| Recruiting Status | Recruiting |
| Condition | Advanced Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Replimune Inc. |
| Last Updated on CT.gov | July 15, 2026 (2 days ago) |
As of July 17, 2026: Clinical trial NCT06264180 is currently recruiting participants. This phase3 study for advanced melanoma is actively seeking new participants at 50 locations across the United States. The study is sponsored by Replimune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06264180 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06264180 was last updated 2 days ago (July 15, 2026). HelloStudys verifies this status automatically.